Philip V. LoGrasso

4.7k total citations
79 papers, 4.0k citations indexed

About

Philip V. LoGrasso is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Philip V. LoGrasso has authored 79 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 28 papers in Organic Chemistry and 10 papers in Computational Theory and Mathematics. Recurrent topics in Philip V. LoGrasso's work include Melanoma and MAPK Pathways (44 papers), Protein Kinase Regulation and GTPase Signaling (29 papers) and Synthesis and biological activity (15 papers). Philip V. LoGrasso is often cited by papers focused on Melanoma and MAPK Pathways (44 papers), Protein Kinase Regulation and GTPase Signaling (29 papers) and Synthesis and biological activity (15 papers). Philip V. LoGrasso collaborates with scholars based in United States, United Kingdom and China. Philip V. LoGrasso's co-authors include Yangbo Feng, Jeremy W. Chambers, Sarah Harper, Shannon Howard, Rongshi Li, Olivier Defert, Michael D. Cameron, Timothy A. Cross, Thomas Schröter and Claudia Ruiz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Philip V. LoGrasso

79 papers receiving 3.9k citations

Peers

Countries citing papers authored by Philip V. LoGrasso

Since Specialization

Citations

This map shows the geographic impact of Philip V. LoGrasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip V. LoGrasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip V. LoGrasso more than expected).

Fields of papers citing papers by Philip V. LoGrasso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip V. LoGrasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip V. LoGrasso. The network helps show where Philip V. LoGrasso may publish in the future.

Co-authorship network of co-authors of Philip V. LoGrasso

This figure shows the co-authorship network connecting the top 25 collaborators of Philip V. LoGrasso. A scholar is included among the top collaborators of Philip V. LoGrasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip V. LoGrasso. Philip V. LoGrasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Amino acid derived quinazolines as Rock/PKA inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Sarwat Chowdhury, Yen‐Ting Chen, X. M. Fang, Wayne Grant, Jennifer Pocas, Michael D. Cameron, Claudia Ruiz, Li Lin, HaJeung Park, Thomas Schröter, Thomas D. Bannister, Philip V. LoGrasso, Yangbo Feng	13
2	Synthesis of Benzoquinone Ansamycin‐Inspired Macrocyclic Lactams from Shikimic Acid 2013 ·Angewandte Chemie International Edition ·(unknown), Sarah Iqbal, (unknown), Michael D. Cameron, HaJeung Park, Philip V. LoGrasso, Glenn C. Micalizio	23
3	Inhibition of JNK Mitochondrial Localization and Signaling Is Protective against Ischemia/Reperfusion Injury in Rats 2012 ·Journal of Biological Chemistry ·Jeremy W. Chambers, Alok S. Pachori, Shannon Howard, Sarah Iqbal, Philip V. LoGrasso	66
4	Discovery of Potent and Selective Covalent Inhibitors of JNK 2012 ·Chemistry & Biology ·Tinghu Zhang, Francisco Iñesta-Vaquera, Mario Niepel, Jianming Zhang, Scott B. Ficarro, Thomas Machleidt, Ting Xie, Jarrod A. Marto, (unknown), Taebo Sim, John D. Laughlin, HaJeung Park, Philip V. LoGrasso, (unknown), Tyzoon Nomanbhoy, Peter K. Sorger, Dario R. Alessi, Nathanael S. Gray	278
5	Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) Inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Yuanjun He, Theodore M. Kamenecka, Youseung Shin, Xinyi Song, Rong Jiang, Romain Noël, Derek R. Duckett, Wei‐Min Chen, Yuan Yuan Ling, Michael D. Cameron, Lin Li, Susan Khan, Marcel Koenig, Philip V. LoGrasso	22
6	Mitochondrial c-Jun N-terminal Kinase (JNK) Signaling Initiates Physiological Changes Resulting in Amplification of Reactive Oxygen Species Generation 2011 ·Journal of Biological Chemistry ·Jeremy W. Chambers, Philip V. LoGrasso	156
7	Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Youseung Shin, Wei‐Ming Chen, Jeff E. Habel, Derek R. Duckett, Yuan Yuan Ling, Marcel Koenig, Yuanjun He, Tomáš Vojkovský, Philip V. LoGrasso, Theodore M. Kamenecka	24
8	Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders 2009 ·Current Topics in Medicinal Chemistry ·Philip V. LoGrasso, Yangbo Feng	59
9	Inhibitors of c-jun-N-Terminal Kinase (JNK) 2008 ·Mini-Reviews in Medicinal Chemistry ·Philip V. LoGrasso, Theodore M. Kamenecka	34
10	Mechanistic characterization for c-jun-N-Terminal Kinase 1α1 2008 ·Archives of Biochemistry and Biophysics ·Brian Ember, Philip V. LoGrasso	9
11	Benzimidazole- and benzoxazole-based inhibitors of Rho kinase 2008 ·Bioorganic & Medicinal Chemistry Letters ·E. Hampton Sessions, Yan Yin, Thomas D. Bannister, Amiee Weiser, (unknown), Jennifer Pocas, Michael D. Cameron, Claudia Ruiz, Lin Li, Stephan C. Schürer, Thomas Schröter, Philip V. LoGrasso, Yangbo Feng	82
12	Chroman-3-amides as potent Rho kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Yen‐Ting Chen, Thomas D. Bannister, Amiee Weiser, (unknown), Lin Li, Claudia Ruiz, Michael D. Cameron, Stephan C. Schürer, Derek R. Duckett, Thomas Schröter, Philip V. LoGrasso, Yangbo Feng	45
13	3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Rong Jiang, Derek R. Duckett, Wei‐Ming Chen, Jeff E. Habel, Yuan Yuan Ling, Philip V. LoGrasso, Theodore M. Kamenecka	35
14	Structure–activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II 2006 ·Bioorganic & Medicinal Chemistry Letters ·Yangbo Feng, Michael D. Cameron, (unknown), (unknown), Lin Li, Claudia Ruiz, Thomas Schröter, Philip V. LoGrasso	39
15	The Structure of JNK3 in Complex with Small Molecule Inhibitors 2003 ·Chemistry & Biology ·Giovanna Scapin, Sangita B. Patel, JeanMarie Lisnock, Joseph W. Becker, Philip V. LoGrasso	102
16	Advances in pain therapeutics 2003 ·Current Opinion in Chemical Biology ·Philip V. LoGrasso, (unknown)	16
17	Characterization and purification of truncated human Rho-kinase II expressed in Sf-21 cells 2002 ·Archives of Biochemistry and Biophysics ·(unknown), (unknown), John W. Trauger, Jeffrey W. Stephens, Philip V. LoGrasso	28
18	Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38 2001 ·Cellular Signalling ·Sarah Harper, Philip V. LoGrasso	270
19	p38 Map Kinase Substrate Specificity Differs Greatly for Protein and Peptide Substrates 2000 ·Archives of Biochemistry and Biophysics ·Julio C. Hawkins, Song Guo Zheng, Betsy Frantz, Philip V. LoGrasso	30
20	Interaction and influence of phenylalanine-198 and threonine-199 on catalysis by human carbonic anhydrase III 1993 ·Biochemistry ·(unknown), Chingkuang Tu, Philip V. LoGrasso, Philip J. Laipis, David N. Silverman	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact